-
Synthetic Skull CT Generation with Generative Adversarial Networks to Train Deep Learning Models for Clinical Transcranial Ultrasound
Authors:
Kasra Naftchi-Ardebili,
Karanpartap Singh,
Reza Pourabolghasem,
Pejman Ghanouni,
Gerald R. Popelka,
Kim Butts Pauly
Abstract:
Deep learning offers potential for various healthcare applications, yet requires extensive datasets of curated medical images where data privacy, cost, and distribution mismatch across various acquisition centers could become major problems. To overcome these challenges, we propose a generative adversarial network (SkullGAN) to create large datasets of synthetic skull CT slices, geared towards tra…
▽ More
Deep learning offers potential for various healthcare applications, yet requires extensive datasets of curated medical images where data privacy, cost, and distribution mismatch across various acquisition centers could become major problems. To overcome these challenges, we propose a generative adversarial network (SkullGAN) to create large datasets of synthetic skull CT slices, geared towards training models for transcranial ultrasound. With wide ranging applications in treatment of essential tremor, Parkinson's, and Alzheimer's disease, transcranial ultrasound clinical pipelines can be significantly optimized via integration of deep learning. The main roadblock is the lack of sufficient skull CT slices for the purposes of training, which SkullGAN aims to address. Actual CT slices of 38 healthy subjects were used for training. The generated synthetic skull images were then evaluated based on skull density ratio, mean thickness, and mean intensity. Their fidelity was further analyzed using t-distributed stochastic neighbor embedding (t-SNE), Fréchet inception distance (FID) score, and visual Turing test (VTT) taken by four staff clinical radiologists. SkullGAN-generated images demonstrated similar quantitative radiological features to real skulls. t-SNE failed to separate real and synthetic samples from one another, and the FID score was 49. Expert radiologists achieved a 60\% mean accuracy on the VTT. SkullGAN makes it possible for researchers to generate large numbers of synthetic skull CT segments, necessary for training neural networks for medical applications involving the human skull, such as transcranial focused ultrasound, mitigating challenges with access, privacy, capital, time, and the need for domain expertise.
△ Less
Submitted 31 January, 2024; v1 submitted 31 July, 2023;
originally announced August 2023.
-
Bridging the gap between prostate radiology and pathology through machine learning
Authors:
Indrani Bhattacharya,
David S. Lim,
Han Lin Aung,
Xingchen Liu,
Arun Seetharaman,
Christian A. Kunder,
Wei Shao,
Simon J. C. Soerensen,
Richard E. Fan,
Pejman Ghanouni,
Katherine J. To'o,
James D. Brooks,
Geoffrey A. Sonn,
Mirabela Rusu
Abstract:
Prostate cancer is the second deadliest cancer for American men. While Magnetic Resonance Imaging (MRI) is increasingly used to guide targeted biopsies for prostate cancer diagnosis, its utility remains limited due to high rates of false positives and false negatives as well as low inter-reader agreements. Machine learning methods to detect and localize cancer on prostate MRI can help standardize…
▽ More
Prostate cancer is the second deadliest cancer for American men. While Magnetic Resonance Imaging (MRI) is increasingly used to guide targeted biopsies for prostate cancer diagnosis, its utility remains limited due to high rates of false positives and false negatives as well as low inter-reader agreements. Machine learning methods to detect and localize cancer on prostate MRI can help standardize radiologist interpretations. However, existing machine learning methods vary not only in model architecture, but also in the ground truth labeling strategies used for model training. In this study, we compare different labeling strategies, namely, pathology-confirmed radiologist labels, pathologist labels on whole-mount histopathology images, and lesion-level and pixel-level digital pathologist labels (previously validated deep learning algorithm on histopathology images to predict pixel-level Gleason patterns) on whole-mount histopathology images. We analyse the effects these labels have on the performance of the trained machine learning models. Our experiments show that (1) radiologist labels and models trained with them can miss cancers, or underestimate cancer extent, (2) digital pathologist labels and models trained with them have high concordance with pathologist labels, and (3) models trained with digital pathologist labels achieve the best performance in prostate cancer detection in two different cohorts with different disease distributions, irrespective of the model architecture used. Digital pathologist labels can reduce challenges associated with human annotations, including labor, time, inter- and intra-reader variability, and can help bridge the gap between prostate radiology and pathology by enabling the training of reliable machine learning models to detect and localize prostate cancer on MRI.
△ Less
Submitted 3 December, 2021;
originally announced December 2021.
-
Weakly Supervised Registration of Prostate MRI and Histopathology Images
Authors:
Wei Shao,
Indrani Bhattacharya,
Simon J. C. Soerensen,
Christian A. Kunder,
Jeffrey B. Wang,
Richard E. Fan,
Pejman Ghanouni,
James D. Brooks,
Geoffrey A. Sonn,
Mirabela Rusu
Abstract:
The interpretation of prostate MRI suffers from low agreement across radiologists due to the subtle differences between cancer and normal tissue. Image registration addresses this issue by accurately map** the ground-truth cancer labels from surgical histopathology images onto MRI. Cancer labels achieved by image registration can be used to improve radiologists' interpretation of MRI by training…
▽ More
The interpretation of prostate MRI suffers from low agreement across radiologists due to the subtle differences between cancer and normal tissue. Image registration addresses this issue by accurately map** the ground-truth cancer labels from surgical histopathology images onto MRI. Cancer labels achieved by image registration can be used to improve radiologists' interpretation of MRI by training deep learning models for early detection of prostate cancer. A major limitation of current automated registration approaches is that they require manual prostate segmentations, which is a time-consuming task, prone to errors. This paper presents a weakly supervised approach for affine and deformable registration of MRI and histopathology images without requiring prostate segmentations. We used manual prostate segmentations and mono-modal synthetic image pairs to train our registration networks to align prostate boundaries and local prostate features. Although prostate segmentations were used during the training of the network, such segmentations were not needed when registering unseen images at inference time. We trained and validated our registration network with 135 and 10 patients from an internal cohort, respectively. We tested the performance of our method using 16 patients from the internal cohort and 22 patients from an external cohort. The results show that our weakly supervised method has achieved significantly higher registration accuracy than a state-of-the-art method run without prostate segmentations. Our deep learning framework will ease the registration of MRI and histopathology images by obviating the need for prostate segmentations.
△ Less
Submitted 23 June, 2021;
originally announced June 2021.
-
ProsRegNet: A Deep Learning Framework for Registration of MRI and Histopathology Images of the Prostate
Authors:
Wei Shao,
Linda Banh,
Christian A. Kunder,
Richard E. Fan,
Simon J. C. Soerensen,
Jeffrey B. Wang,
Nikola C. Teslovich,
Nikhil Madhuripan,
Anugayathri Jawahar,
Pejman Ghanouni,
James D. Brooks,
Geoffrey A. Sonn,
Mirabela Rusu
Abstract:
Magnetic resonance imaging (MRI) is an increasingly important tool for the diagnosis and treatment of prostate cancer. However, interpretation of MRI suffers from high inter-observer variability across radiologists, thereby contributing to missed clinically significant cancers, overdiagnosed low-risk cancers, and frequent false positives. Interpretation of MRI could be greatly improved by providin…
▽ More
Magnetic resonance imaging (MRI) is an increasingly important tool for the diagnosis and treatment of prostate cancer. However, interpretation of MRI suffers from high inter-observer variability across radiologists, thereby contributing to missed clinically significant cancers, overdiagnosed low-risk cancers, and frequent false positives. Interpretation of MRI could be greatly improved by providing radiologists with an answer key that clearly shows cancer locations on MRI. Registration of histopathology images from patients who had radical prostatectomy to pre-operative MRI allows such map** of ground truth cancer labels onto MRI. However, traditional MRI-histopathology registration approaches are computationally expensive and require careful choices of the cost function and registration hyperparameters. This paper presents ProsRegNet, a deep learning-based pipeline to accelerate and simplify MRI-histopathology image registration in prostate cancer. Our pipeline consists of image preprocessing, estimation of affine and deformable transformations by deep neural networks, and map** cancer labels from histopathology images onto MRI using estimated transformations. We trained our neural network using MR and histopathology images of 99 patients from our internal cohort (Cohort 1) and evaluated its performance using 53 patients from three different cohorts (an additional 12 from Cohort 1 and 41 from two public cohorts). Results show that our deep learning pipeline has achieved more accurate registration results and is at least 20 times faster than a state-of-the-art registration algorithm. This important advance will provide radiologists with highly accurate prostate MRI answer keys, thereby facilitating improvements in the detection of prostate cancer on MRI. Our code is freely available at https://github.com/pimed//ProsRegNet.
△ Less
Submitted 2 December, 2020;
originally announced December 2020.
-
CorrSigNet: Learning CORRelated Prostate Cancer SIGnatures from Radiology and Pathology Images for Improved Computer Aided Diagnosis
Authors:
Indrani Bhattacharya,
Arun Seetharaman,
Wei Shao,
Rewa Sood,
Christian A. Kunder,
Richard E. Fan,
Simon John Christoph Soerensen,
Jeffrey B. Wang,
Pejman Ghanouni,
Nikola C. Teslovich,
James D. Brooks,
Geoffrey A. Sonn,
Mirabela Rusu
Abstract:
Magnetic Resonance Imaging (MRI) is widely used for screening and staging prostate cancer. However, many prostate cancers have subtle features which are not easily identifiable on MRI, resulting in missed diagnoses and alarming variability in radiologist interpretation. Machine learning models have been developed in an effort to improve cancer identification, but current models localize cancer usi…
▽ More
Magnetic Resonance Imaging (MRI) is widely used for screening and staging prostate cancer. However, many prostate cancers have subtle features which are not easily identifiable on MRI, resulting in missed diagnoses and alarming variability in radiologist interpretation. Machine learning models have been developed in an effort to improve cancer identification, but current models localize cancer using MRI-derived features, while failing to consider the disease pathology characteristics observed on resected tissue. In this paper, we propose CorrSigNet, an automated two-step model that localizes prostate cancer on MRI by capturing the pathology features of cancer. First, the model learns MRI signatures of cancer that are correlated with corresponding histopathology features using Common Representation Learning. Second, the model uses the learned correlated MRI features to train a Convolutional Neural Network to localize prostate cancer. The histopathology images are used only in the first step to learn the correlated features. Once learned, these correlated features can be extracted from MRI of new patients (without histopathology or surgery) to localize cancer. We trained and validated our framework on a unique dataset of 75 patients with 806 slices who underwent MRI followed by prostatectomy surgery. We tested our method on an independent test set of 20 prostatectomy patients (139 slices, 24 cancerous lesions, 1.12M pixels) and achieved a per-pixel sensitivity of 0.81, specificity of 0.71, AUC of 0.86 and a per-lesion AUC of $0.96 \pm 0.07$, outperforming the current state-of-the-art accuracy in predicting prostate cancer using MRI.
△ Less
Submitted 31 July, 2020;
originally announced August 2020.
-
Registration of pre-surgical MRI and whole-mount histopathology images in prostate cancer patients with radical prostatectomy via RAPSODI
Authors:
Mirabela Rusu,
Christian A. Kunder,
Nikola C. Teslovich,
Jeffrey B Wang,
Rewa R. Sood,
Wei Shao,
Leo C. Chan,
Robert West,
Richard Fan,
Pejman Ghanouni,
James B. Brooks,
Geoffrey A. Sonn
Abstract:
Magnetic resonance imaging (MRI) has great potential to improve prostate cancer diagnosis. It can spare men with a normal exam from undergoing invasive biopsy while making biopsies more accurate in men with lesions suspicious for cancer. Yet, the subtle differences between cancer and confounding conditions, render the interpretation of MRI challenging. The tissue collected from patients that under…
▽ More
Magnetic resonance imaging (MRI) has great potential to improve prostate cancer diagnosis. It can spare men with a normal exam from undergoing invasive biopsy while making biopsies more accurate in men with lesions suspicious for cancer. Yet, the subtle differences between cancer and confounding conditions, render the interpretation of MRI challenging. The tissue collected from patients that undergo pre-surgical MRI and radical prostatectomy provides a unique opportunity to correlate histopathology images of the entire prostate with MRI in order to accurately map the extent of prostate cancer onto MRI. Here, we introduce the RAPSODI (framework for the registration of radiology and pathology images. RAPSODI relies on a three-step procedure that first reconstructs in 3D the resected tissue using the serial whole-mount histopathology slices, then registers corresponding histopathology and MRI slices, and finally maps the cancer outlines from the histopathology slices onto MRI. We tested RAPSODI in a phantom study where we simulated various conditions, e.g., tissue specimen rotation upon mounting on glass slides, tissue shrinkage during fixation, or imperfect slice-to-slice correspondences between histology and MRI. Our experiments showed that RAPSODI can reliably correct for rotations within $\pm15^{\circ}$ and shrinkage up to 10%. We also evaluated RAPSODI in 89 patients from two institutions that underwent radical prostatectomy, yielding 543 histopathology slices that were registered to corresponding T2 weighted MRI slices. We found a Dice coefficient of 0.98$ \pm $0.01 for the prostate, prostate boundary Hausdorff distance of 1.71$ \pm $0.48 mm, a urethra deviation of 2.91$ \pm $1.25 mm, and a landmark deviation of 2.88$ \pm $0.70 mm between registered histopathology images and MRI. Our robust framework successfully mapped the extent of disease from histopathology slices onto MRI.
△ Less
Submitted 21 September, 2019; v1 submitted 30 June, 2019;
originally announced July 2019.